Dipyrone use during pregnancy and adverse perinatal events

Archives of Gynecology and Obstetrics

Volumn 279, Issue 3, 2009, Pages 293-297

  Da Silva Dal Pizzol, Tatiane ^a   Schüler Faccini, Lavínia ^a   Mengue, Sotero Serrate ^a   Fischer, Maria Isabel ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Congenital abnormalities; Dipyrone; Intrauterine death; Low birth weight; Preterm birth

Indexed keywords

DIPYRONE;

ADULT; ANENCEPHALUS; ARTICLE; CHOANA ATRESIA; CLUBFOOT; DISEASE ASSOCIATION; DRUG USE; FEMALE; FETUS DEATH; FOLLOW UP; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MACROCEPHALY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENINGOMYELOCELE; POLYDACTYLY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; STRUCTURED QUESTIONNAIRE; SYNDACTYLY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DIPYRONE; FEMALE; HUMANS; INFANT, NEWBORN; MULTIVARIATE ANALYSIS; PREGNANCY; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 58849163088     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0707-3     Document Type: Article

References (16)

1. The international agranulocytosis aplastic anemia study 1986 Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics JAMA 256 1749 1757 10.1001/jama.256.13. 1749
2. F Andersohn C Konzen E Garbe 2007 Systematic review: agranulocytosis induced by nonchemotherapy drugs Ann Intern Med 146 657 665
3. International panel on the evaluation of safety of dipyrone use (on line) (2007). Available on 20 April 2007 at http://www.anvisa.gov.br/divulga/ informes/relatoriodipirona2.pdf
4. SS Mengue EP Shenkel BB Duncan MI Schmidt 2001 Drug use by pregnant women in six Brazilian cities Rev Saude Publica 35 415 420 10.1590/S0034- 89102001000500002
5. MR Fonseca E Fonseca G Bergsten-Mendes 2002 Prevalence of drug use during pregnancy: a pharmacoepidemiology approach Rev Saude Publica 36 205 212
6. CR Sharpe EL Franco 1996 Use of dipyrone during pregnancy and risk of Wilm's tumor Epidemiology 7 533 535 10.1097/00001648-199609000-00014
7. FE Alexander SL Patheal A Biondi S Brandalise ME Cabrera C Chan Li 2001 Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion Cancer Res 61 2542 2546
8. JL Catalán J Santonja L Martinez NV Jiménez 1994 Oligoamnios asociado al uso de dipirona Med Clin (Barc) 105 541 543
9. MD Sánchez de la Nieta F Rivera M de la Torre R Alcázar G Caparrós M Paz Alcaide 2003 Acute renal failure and oligohydramnios induced by magnesium dipyrone (metamizol) in a pregnant women Nephrol Dial Transplant 18 1679 1680 10.1093/ndt/gfg240
10. A Weintraub D Mankuta 2006 Dipyrone-induced oligohydramnios and ductus arteriosus restriction Isr Med Assoc J 8 722 723
11. JJ Martí Solé M Pasarisas Sala 1996 Possible association between the administration of metamizol to mothers and persistent pulmonary hypertension in neonates An Esp Pediatr 44 387 388
12. B Bar-Oz M Clementi E di Giantonio 2005 Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study Eur J Obstet Gynecol Reprod Biol 119 176 179 10.1016/j.ejogrb.2004.07.004
13. F Bánhidy N Ács E Puhó AE Czeizel 2007 A population-based case-control teratologic study of oral dipyrone treatment during pregnancy Drug Saf 30 59 70 10.2165/00002018-200730010-00006
14. Brazil. Ministry of Health. Secretary of ScienceTechnology Strategic Products. Department of Pharmaceutical Assistance Strategic Products (2007) National list of essential medicines-RENAME, 4th edn. Ministry of Health Press, Brasília, p 285
15. K Izumi N Sano H Otsuka T Kinouchi Y Ohnishi 1991 Tumor promoting potential in male F344 rats and mutagenicity in Salmonella typhimurium of dipyrone Carcinogenesis 12 1221 1225 10.1093/carcin/12.7.1221
16. AK Giri A Mukhopadhyay 1998 Mutagenicity assay in Salmonella and in vivo sister chromatid exchange in bone marrow cells of mice for four pyrazolone derivatives Mutat Res 420 15 25